ArticleCancer chemotherapy and pharmacology2015

Preclinical assessment of the interactions between the antiretroviral drugs, ritonavir and efavirenz, and the tyrosine kinase inhibitor erlotinib.

John F Deeken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.